HIGHLIGHTS
- What: The authors aimed to assess whether a predefined schedule to taper the high-dose and long-acting GC used in patients with COVID-19 can prevent adrenal crisis after GC discontinuation. The aim of any GC therapy is to prescribe the lowest effective dose for the shortest possible time.
- Who: Hormones ( and collaborators from the the University Hospital of Padova with , infectionA total of , patients were treated with dexamethasone, after have published the research: (2024) 23:753-758 A schedule for tapering glucocorticoid treatment in patients with severe SARS-CoV infection can prevent acute . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.